April 3, 2026
A new study showed that among patients with acne, taking daily doxycycline reduced the likelihood of acquiring a sexually transmitted infection (STI) by more than 25%. […]
April 2, 2026
TOPLINE: In a retrospective analysis, immune-related pruritus (irPruritus) affected nearly one quarter of patients with metastatic melanoma undergoing immune checkpoint inhibitor (ICI) therapy, with combination therapy […]
April 2, 2026
The management of moderate-to-severe psoriasis has advanced over the past decade with the introduction of biologic therapies targeting interleukin (IL)-17A and IL-23. IL-17A inhibitors are associated […]
April 2, 2026
Among patients who used indoor tanning, melanoma was diagnosed nearly 10 years earlier than among those who had never used indoor tanning, according to a Canadian […]
April 2, 2026
TOPLINE: A randomized study found that topical probiotics in soybean concentrate significantly improved complete healing rates and shortened healing time in diabetic foot ulcers (DFUs) compared […]
April 1, 2026
DENVER — Adding the weight-loss drug tirzepatide to the biologic ixekizumab significantly improved joint and skin outcomes in patients with psoriatic arthritis (PsA) and overweight or […]
April 1, 2026
TOPLINE: In a Danish study, patients with chronic lymphocytic leukemia (CLL) showed a higher risk for skin cancer, metastasis, and death than matched individuals at 10 […]
March 31, 2026
DENVER — The selective tyrosine kinase 2 (TYK2) inhibitor envudeucitinib emerged superior to apremilast and placebo in two phase 3 trials of people with moderate-to-severe psoriasis. […]
March 30, 2026
TOPLINE: Superficial radiation therapy (SRT) cost considerably more than Mohs micrographic surgery (MMS) for nonmelanoma skin cancer treatment, according to a Medicare data analysis. METHODOLOGY: Researchers […]